http://rdf.ncbi.nlm.nih.gov/pubchem/patent/NO-931246-L

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_70a0919564cd6d43eac5a20c7ce430c0
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-70
classificationIPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H19-24
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-405
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D498-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D209-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D209-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-495
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D209-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K-
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-505
filingDate 1993-03-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_048dd3e60bcfc7491b539df7268f0784
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e0f8ea4985c9d223f37ab025821bdfbe
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_96a1556ba74d3774d455aa3e42a6b16a
publicationDate 1993-10-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber NO-931246-L
titleOfInvention COMPOSITIONS FOR TREATING INFECTION AND DISEASE CAUSED BY HEPATITES B VIRUS (HBV)
abstract Pharmaceutical compositions useful for treating individuals suffering from an infection or disease caused by hepatitis B virus (HBV) are described. In particular, it has been discovered that administration of low doses of 1- (2'-deoxy-2'-fluoro-BD-arabino-furanosyl) -5-iodouracil (FIAU) to people chronically infected with HBV can effectively reduce circulating markers associated with HBV. Methods for the preparation of pharmaceutical antiviral compositions are also described.
priorityDate 1992-04-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID50313
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419760640

Total number of triples: 28.